Episodic memory loss is related to hippocampal-mediated β-amyloid deposition in elderly subjects

Brain

Volumn 132, Issue 5, 2009, Pages 1310-1323

  Mormino, E C ^a   Kluth, J T ^b   Madison, C M ^a   Rabinovici, G D ^a,b,c   Baker, S L ^b   Miller, B L ^c   Koeppe, R A ^d   Mathis, C A ^e   Weiner, M W ^f   Jagust, W J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

amyloid; Hippocampus; Magnetic resonance imaging; Pittsburgh Compound B; Preclinical Alzheimers disease

Indexed keywords

AMYLOID BETA PROTEIN;

AGED; AGING; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; COGNITIVE DEFECT; CONTROLLED STUDY; EPISODIC MEMORY; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE;

AGE FACTORS; AGED; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANILINE COMPOUNDS; ATROPHY; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; EDUCATIONAL STATUS; FEMALE; HIPPOCAMPUS; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGAN SIZE; POSITRON-EMISSION TOMOGRAPHY; PSYCHIATRIC STATUS RATING SCALES; RADIOPHARMACEUTICALS; SEX FACTORS; THIAZOLES;

EID: 66549127860     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awn320     Document Type: Article

References (70)

1. Aizenstein HJ, Nebes RD, Saxton JA, Price JC, Mathis CA, Tsopelas ND, et al. Amyloid deposition is frequent and often is not associated with signi?cant cognitive impairment in the elderly. Arch Neurol 2008; 65: 1509-17
2. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006; 63: 693-9
3. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neuro?brillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991; 1: 103-16
4. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986; 51: 1173-82
5. Bennett DA, Schneider JA, Arvanitakis Z, Kelly JF, Aggarwal NT, Shah RC, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006; 66: 1837-44. (Pubitemid 44049813)
6. Bennett DA, Schneider JA, Wilson RS, Bienias JL, Arnold SE. Neuro?brillary tangles mediate the association of amyloid load with clinical Alzheimer disease and level of cognitive function. Arch Neurol 2004; 61: 378-84. (Pubitemid 38327357)
7. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
8. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18: 351-7 (Pubitemid 27435070)
9. Buckner RL, Head D, Parker J, Fotenos AF, Marcus D, Morris JC, et al. A unified approach for morphometric and functional data analysis in young, old, and demented adults using automated atlas-based head size normalization: reliability and validation against manual measurement of total intracranial volume. Neuroimage 2004; 23: 724-38 (Pubitemid 39370623)
10. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9: 179-94
11. Davis DG, Schmitt FA, Wekstein DR, Markesbery WR. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 1999; 58: 376-88 (Pubitemid 29187900)
12. de Leon MJ, Convit A, George AE, Golomb J, de Santi S, Tarshish C, et al. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann N Y Acad Sci 1996; 777: 1-13. (Pubitemid 26149164)
13. Delis D, Kramer J, Kaplan E, Ober B. California verbal learning test. San Antonio: The Psychological Corporation; 2000.
14. Desikan RS, Segonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, et al. An automated labeling system for subdividing the human cere-bral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006; 31: 968-80 (Pubitemid 44183792)
15. Fagan AM, Mintun MA, Mach RH, Lee SY, Dence CS, Shah AR, et al. Inverse relation between in vivo amyloid imaging load and cerebrosp-inal ?uid Abeta42 in humans. Ann Neurol 2006; 59: 512-9 (Pubitemid 43358072)
16. Fischl B, Liu A, Dale AM. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans Med Imaging 2001; 20: 70-80. (Pubitemid 32293421)
17. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002; 33: 341-55 (Pubitemid 34162530)
18. Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, et al. PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 2008; 29: 1456-1465
19. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging: evidence for a relation between socioeco-nomic status, preclinical Alzheimer disease, and reserve. Arch Neurol 2008; 65: 113-120
20. Goldman WP, Price JL, Storandt M, Grant EA, McKeel DW Jr, Rubin EH, et al. Absence of cognitive impairment or decline in preclinical Alzheimer's disease. Neurology 2001; 56: 361-367 (Pubitemid 32144148)
21. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004; 101: 4637-42 (Pubitemid 38437463)
22. Grober E, Hall CB, Lipton RB, Zonderman AB, Resnick SM, Kawas C. Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease. J Int Neuropsychol Soc 2008; 14: 266-78
23. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: pro-gress and problems on the road to therapeutics. Science 2002; 297: 353-6 (Pubitemid 34790756)
24. Hulette CM, Welsh-Bohmer KA, Murray MG, Saunders AM, Mash DC, McIntyre LM. Neuropathological and neuropsychological changes in 'normal' aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J Neuropathol Exp Neurol 1998; 57: 1168-74 (Pubitemid 28562746)
25. Jack CR Jr, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 2008a; 27: 685-691
26. Jack CR Jr, Dickson DW, Parisi JE, Xu YC, Cha RH, O'Brien PC, et al. Antemortem MRI ?ndings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002; 58: 750-7 (Pubitemid 34211554)
27. Jack CR Jr, Lowe VJ, Senjem ML, Weigand SD, Kemp BJ, Shiung MM, et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008b; 131: 665-80
28. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999; 52: 1397-1403 (Pubitemid 29190530)
29. Jicha GA, Parisi JE, Dickson DW, Johnson K, Cha R, Ivnik RJ, et al. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch Neurol 2006; 63: 674-81
30. Katzman R, Terry R, DeTeresa R, Brown T, Davies P, Fuld P, et al. Clinical, pathological, and neurochemical changes in dementia: a sub-group with preserved mental status and numerous neocortical plaques. Ann Neurol 1988; 23: 138-44 (Pubitemid 18081451)
31. Kemppainen NM, Aalto S, Karrasch M, Nagren K, Savisto N, Oikonen V, et al. Cognitive reserve hypothesis: Pittsburgh Compound B and ?uor-odeoxyglucose positron emission tomography in relation to education in mild Alzheimer's disease. Ann Neurol 2008; 63: 112-8
32. Kemppainen NM, Aalto S, Wilson IA, Nagren K, Helin S, Bruck A, et al. Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 2006; 67: 1575-80 (Pubitemid 44747926)
33. Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306-319 (Pubitemid 38269583)
34. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, et al. Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 2003; 62: 1087-1095 (Pubitemid 37413820)
35. Kramer JH, Jurik J, Sha SJ, Rankin KP, Rosen HJ, Johnson JK, et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol 2003; 16: 211-218 (Pubitemid 37517826)
36. Langstrom B, Antoni G, Gullberg P, Halldin C, Malmborg P, Nagren K, et al. Synthesis of L- and D-[methyl-11C]methionine. J Nucl Med 1987; 28: 1037-40 (Pubitemid 17086825)
37. Link JM, Krohn KA, Clark JC. Production of [11C]CH3I by single pass reaction of [11C]CH4 with I2. Nucl Med Biol 1997; 24: 93-7
38. Lockhart A, Lamb JR, Osredkar T, Sue LI, Joyce JN, Ye L, et al. PIB is a non-speci?c imaging marker of amyloid-beta (Abeta) peptide-related cerebral amyloidosis. Brain 2007; 130: 2607-15 (Pubitemid 47511709)
39. Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff DL. Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 1996; 16: 834-40 (Pubitemid 26292051)
40. Mathalon DH, Sullivan EV, Rawles JM, Pfefferbaum A. Correction for head size in brain-imaging measurements. Psychiatry Res 1993; 50: 121-39 (Pubitemid 23187108)
41. Mathis CA, Wang Y, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothia- zoles as amyloid imaging agents. J Med Chem 2003; 46: 2740-54 (Pubitemid 36702542)
42. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-44 (Pubitemid 14076461)
43. Meltzer CC, Kinahan PE, Greer PJ, Nichols TE, Comtat C, Cantwell MN, et al. Comparative evaluation of MR-based partial-volume correction schemes for PET. J Nucl Med 1999; 40: 2053-2065 (Pubitemid 30022022)
44. Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, et al. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease. Nature 2008; 451: 720-4
45. Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, et al. [ 11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 2006; 67: 446-52 (Pubitemid 44214969)
46. Morris JC. The clinical dementia rating (CDR): current version and scoring rules. Neurology 1993; 43: 2412-4 (Pubitemid 23346995)
47. Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007; 130: 2837-44 (Pubitemid 350033975)
48. Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, et al. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 2005; 25: 1528-47 (Pubitemid 41541962)
49. Price JL, Morris JC. Tangles and plaques in nondemented aging and 'preclinical' Alzheimer's disease. Ann Neurol 1999; 45: 358-68 (Pubitemid 29120041)
50. Ranganath C, Heller A, Cohen MX, Brozinsky CJ, Rissman J. Functional connectivity with the hippocampus during successful memory formation. Hippocampus 2005; 15: 997-1005. (Pubitemid 43056989)
51. Raz N, Rodrigue KM. Differential aging of the brain: patterns, cognitive correlates and modi?ers. Neurosci Biobehav Rev 2006; 30: 730-48 (Pubitemid 44292292)
52. Reitan RM. Validity of the trailmaking test as an indication of organic brain damage. Percept Mot Skills 1958; 8: 271-6
53. Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, et al. Imaging beta-amyloid burden in aging and dementia. Neurology 2007; 68: 1718-25 (Pubitemid 46763260)
54. Salthouse TA, Babcock RL, Shaw RJ. Effects of adult age on structural and operational capacities in working memory. Psychol Aging 1991; 6: 118-27.
55. Salthouse TA, Babcock RL, Shaw RJ. Effects of adult age on structural and operational capacities in working memory. Psychol Aging 1991; 6: 118-27.
56. FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR. 'Preclinical' AD revisited: neuropathology of cognitively normal older adults. Neurology 2000; 55: 370-6 (Pubitemid 30654797)
57. Segonne F, Dale AM, Busa E, Glessner M, Salat D, Hahn HK, et al. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004; 22: 1060-75 (Pubitemid 38829195)
58. Small BJ, Fratiglioni L, Viitanen M, Winblad B, Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 2000; 57: 839-44 (Pubitemid 30397186)
59. Small SA, Stern Y, Tang M, Mayeux R. Selective decline in memory function among healthy elderly. Neurology 1999; 52: 1392-6 (Pubitemid 29190529)
60. Smith CD, Chebrolu H, Wekstein DR, Schmitt FA, Jicha GA, Cooper G, et al. Brain structural alterations before mild cognitive impairment. Neurology 2007; 68: 1268-73 (Pubitemid 46625972)
61. Stern Y. Cognitive reserve and Alzheimer disease. Alzheimer Dis Assoc Disord 2006; 20: S69-S74. (Pubitemid 44265854)
62. Tomlinson BE, Blessed G, Roth M. Observations on the brains of non-demented old people. J Neurol Sci 1968; 7: 331-56
63. Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, et al. Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease. Neuropsycho- logia 2008; 46: 1688-97
64. Walsh DM, Selkoe DJ. A beta oligomers-a decade of discovery. J Neurochem 2007; 101: 1172-84
65. Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease: evidence from resting state fMRI. Neuroimage 2006; 31: 496-504. (Pubitemid 43776683)
66. Wechsler D. Wechsler adult intelligence scale-revised. San Antonio: The Psychological Corporation; 1987.
67. Wechsler D. Wechsler memory scale-revised. San Antonio: The Psychological Corporation; 1987b.
68. 11C]-6-OH-BTA-1). J Labelled Compounds and Radiopharmaceuticals 2004; 47: 679-82 (Pubitemid 39390042)
69. Zaidi H, Ruest T, Schoenahl F, Montandon ML. Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. Neuroimage 2006; 32: 1591-607 (Pubitemid 44332287)
70. Zec RF. The stroop color-word test: A paradigm for procedural learning. Arch Clin Neuropsychol 1986; 1: 274-5